Liver Transplant CGM

Part of paid clinical trials in New York, New York.

Sponsor
Icahn School of Medicine at Mount Sinai
Study ID
NCT07216508
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Libre 3+ — DEVICE
    Blinded CGM will be worn by all participants

Study Details

This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.

Key Dates

Start date
Oct 13, 2025
Status verified
Nov 2025
Primary completion
Oct 5, 2026
Completion
Oct 5, 2027

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: Participants post liver transplant
    Participants who are discharged from after liver transplant.

Primary Outcome Measure

Time in range [ Time Frame: 28 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mount Sinai HospitalNew YorkNew York10029
Grenye O'Malley, MD
grenye.o'[email protected]
212-241-7173
Alexa Brett
[email protected]
212-241-7586
Grenye O'Malley (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Mount Sinai Hospital· New York, NY

Related Studies